Project Grant 2103436

Award Date 6/15/21
Completion Date 5/31/22
Dollars Obligated $256K
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19146, USA
Similar Awards
This National Science Foundation (NSF) Cooperative Agreement award, provided through the NSF Technology, Innovation, and Partnerships (CFDA #47.084) program, funds the development of a novel, fully implantable craniofacial distraction system by Ostiio LLC, a medical device company based in Philadelphia, PA. The $1,000,000 award aims to produce a magnetic, subcutaneous distraction device capable of gradually correcting skeletal abnormalities affecting craniomaxillofacial functions such as...
The National Science Foundation Division of Industrial Innovation awarded Osciflex LLC a $999,727 cooperative agreement from October 15, 2021 to September 30, 2023 under the Engineering (47.041) federal grant program. The award will support Osciflex's development of a portable rapid cycling compression device to prevent blood clots. As part of its mission to improve the nation's quality of life and economic strength through engineering innovation, the NSF Directorate for Engineering seeks...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $305,000 to Magsorbeo Biomedical Corp aims to develop a bioabsorbable magnesium alloy for maxillofacial fixation. The project will demonstrate the feasibility of a custom-tailored absorption profile for this magnesium alloy implant, which could improve healing and eliminate the need for secondary removal surgeries that currently cost the U.S. healthcare system $1.72 billion...
The National Science Foundation (NSF) awarded a $275,000 Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Orthomechanica, Inc. This SBIR Phase I grant is supporting the development of a novel implantable medical device for restoring movement and recovery during reconstructive surgery. The key objectives are to design, fabricate, and validate a prototype implant that can chronically integrate with tendons to reroute movement from a single tendon to...
The National Science Foundation Division of Industrial Innovation awarded a $256,000 Project Grant to develop an automatic debridement device from August 1, 2021 through March 31, 2022. This Small Business Innovation Research Phase I award under the Engineering (47.041) program will support the creation of a product to automatically remove dead, damaged, or infected tissue. The NSF Directorate for Engineering seeks to foster innovation and excellence in engineering research, consistent with...
The National Science Foundation awarded a $255,805 Small Business Innovation Research Phase I Project Grant to Ossillate Inc. of Auburn, Alabama for work conducted from August 1, 2021 through July 31, 2022. Under the grant, Ossillate will research securing the open source software supply chain as part of the NSF's Engineering program (CFDA #47.041). The NSF Engineering directorate seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering...
Nostopharma LLC was awarded a $256,000 Small Business Technology Transfer Phase I Project Grant from the National Science Foundation to develop a sustained-release, biodegradable nanoparticle drug delivery system for treatment of soft tissue trauma complications. Funded under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084), the 12-month project beginning March 1, 2022 aims to demonstrate in vitro and in vivo feasibility of modulating the ectopic bone microenvironment...
The National Science Foundation awarded a $256,000 Small Business Innovation Research Phase I Project Grant to Current Surgical Inc. from May 15, 2021 to November 30, 2021 under the Engineering program (CFDA 47.041). The grant funds the development of a smart needle for precise tumor ablation. The NSF Engineering program supports innovation, creativity, and excellence in engineering research and education to improve quality of life and economic strength. This award advances those goals by...
Innovision LLC received a $255,735 Project Grant award from the National Science Foundation on January 15, 2022 to complete work by September 30, 2022. The award was made under the NSF Engineering program (CFDA 47.041) to develop a patient digital twin and performance capture system for scoliosis physiotherapy. The system will utilize integrated digital environments, parametric musculoskeletal models, and dynamic avatars to simulate human-robot interaction for scoliosis treatment. Such...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award to Reselute, Inc. provides $998,921 to develop a novel implantable orthopedic medical device and procedure to reduce recovery duration and infection risks associated with severe traumatic fractures of the long bones. The project aims to advance a 3D-printed, antibiotic-releasing intramedullary nail to improve upon current standard-of-care implants that are prone to...

Ostiio LLC received a $256,000 Project Grant award from the National Science Foundation on June 15, 2021 to support research and development activities concluding on May 31, 2022. The grant was awarded under the NSF's Engineering program (CFDA #47.041), which aims to improve quality of life and economic strength through engineering innovation and excellence.

Specifically, the funding will support Ostiio's efforts to miniaturize a magnetic craniofacial distraction system. The company is located in Philadelphia, Pennsylvania and will leverage the grant to advance development of technologies with the potential to improve craniofacial reconstruction procedures. No sub-awards were indicated. The award demonstrates the NSF's commitment to translating engineering research into solutions with real-world medical applications.

Generated 1/6/24, 12:56 PM